Long-term outcomes after Helicobacter pylori eradication with second-line, bismuth-containing quadruple therapy in Korea

European Journal of Gastroenterology and Hepatology

Volumn 18, Issue 5, 2006, Pages 515-519

  Cheon, Jae Hee ^a   Kim, Nayoung ^b   Lee, Dong Ho ^b   Kim, Jung Mogg ^c   Kim, Joo Sung ^a   Jung, Hyun Chae ^a   Song, In Sung ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

^c Hanyang University College of Medicine   (South Korea)

Author keywords

Bismuth; Helicobacter pylori; Quadruple; Recrudescence; Reinfection; Second line

Indexed keywords

ANTIBIOTIC AGENT; BISMUTH CITRATE; CLARITHROMYCIN; METRONIDAZOLE; OMEPRAZOLE; PANTOPRAZOLE; TETRACYCLINE;

ADULT; AGE DISTRIBUTION; AGED; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REGIMEN; DYSPEPSIA; ERADICATION THERAPY; FEMALE; FOLLOW UP; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; INFECTION RATE; KOREA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PEPTIC ULCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; REINFECTION; RELAPSE; SEX DIFFERENCE; TREATMENT FAILURE;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; ANTI-ULCER AGENTS; DRUG THERAPY, COMBINATION; DYSPEPSIA; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; KOREA; MALE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; PEPTIC ULCER; RECURRENCE; TREATMENT OUTCOME;

EID: 33744786268     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200605000-00010     Document Type: Article

References (42)

1. Forbes GM, Glaser ME, Cullen DJ, Warren JR, Christiansen KJ, Marshall BJ, et al. Duodenal ulcer treated with Helicobacter pylori eradication: seven-year follow-up. Lancet 1994; 343:258-260.
2. Hildebrand P, Bardhan P, Rossi L, Parvin S, Rahman A, Arefin MS, et al. Recrudescence and reinfection with Helicobacter pylori after eradication therapy in Bangladeshi adults. Gastroenterology 2001; 121:792-798.
3. Borody TJ, Andrews P, Mancuso N, McCauley D, Jankiewicz E, Ferch N, et al. Helicobacter pylori reinfection rate, in patients with cured duodenal ulcer. Am J Gastroenterol 1994; 89:529-532.
4. Bell GD, Powell KU. Helicobacter pylori reinfection after apparent eradication - the Ipswich experience. Scand J Gastroenterol Suppl 1996; 215:96-104.
5. Feydt-Schmidt A, Kindermann A, Konstantopoulos N, Demmelmair H, Ballauff A, Findeisen A, et al. Reinfection rate in children after successful Helicobacter pylori eradication. Eur J Gastroenterol Hepatol 2002; 14:1119-1123.
6. Powell KU, Bell GD, Bolton GH, Burridge SM, Bowden AF, Rameh B, et al. Helicobacter pylori eradication in patients with peptic ulcer disease: clinical consequences and financial implications. Q J Med 1994; 87:283-290.
7. van der Hulst RW, Rauws EA, Koycu B, Keller JJ, ten Kate FJ, Dankert J, et al. Helicobacter pylori reinfection is virtually absent after successful eradication. J Infect Dis 1997; 176:196-200.
8. Zhou LY, Lin SR, Shen ZY, Zhong SZ, Ding SG, Huang XB, et al. Five-year follow-up study after Helicobacter pylori eradication: reinfection and peptic ulcer status. Chin J Dig 2003; 4:45-48.
9. Kim N, Lim SH, Lee KH, Jung HC, Song IS, Kim CY. Helicobacter pylori reinfection rate and duodenal ulcer recurrence in Korea. J Clin Gastroenterol 1998; 27:321-326.
10. Song JB, Lee SH, Shin YM, Choi KH, Lee SD, Park YH. Seroprevalence of Helicobacter pylori infection in patients without gastric symptoms. Korean J Gastroenterol 1997; 29:310-316.
11. Kim JH, Kim HY, Kim NY, Kim SW, Kim JG, Kim JJ, et al. Seroprevalence of Helicobacter pylori infection in asymptomatic people in Korea. Korean J Internal Med 2000; 59:388-397.
12. Raymond J, Thiberg JM, Chevalier C, Kalach N, Bergeret M, Labigne A, et al. Genetic and transmission analysis of Helicobacter pylori strains within a family. Emerg Infect Dis 2004; 10:1816-1821.
13. Ueda M, Kikuchi S, Kasugai T, Shunichi T, Miyake C. Helicobacter pylori risk associated with childhood home environment. Cancer Sci 2003; 94:914-918.
14. Chung WC, Cho YS, Jeong JJ, Lee IS, Kim SW, Yang JM, et al. Eradication rate of Helicobacter pylori according to the disease and therapeutic regimens, and reinfection rate after successful eradication in a tertiary clinic. Korean J Gastroenterol 2003; 41:1-8.
15. Lee JY, Kim W, Gwak GY, Park SC, Ye BD, Lee SH, et al. Reinfection rate and clinical manifestation of Helicobacter pylori-positive peptic ulcer disease after triple therapy containing clarithromycin. Korean J Gastroenterol 2002; 39:93-100.
16. Ko JS, Choe YH, Seo JK. Helicobacter pylori infection in children after eradication. Korean J Gastroenterol 1997; 30:574-581.
17. Adachi M, Mizuno M, Yokota K, Miyoshi M, Nagahara Y, Maga T, et al. Reinfection rate following effective therapy against Helicobacter pylori infection in Japan. J Gastroenterol Hepatol 2002; 17:27-31.
18. Louw JA, Lucke W, Jaskiewicz K, Lastovica AJ, Winter TA, Marks IN. Helicobacter pylori eradication in the African setting, with special reference to reinfection and duodenal ulcer recurrence. Gut 1995; 36:544-547.
19. van der Wouden EJ, Thijs JC, van Zwet AA, Kleibeuker JH. Six-year follow-up after successful triple therapy for Helicobacter pylori infection in patients with peptic ulcer disease. Eur J Gastroenterol Hepatol 2001; 13:1235-1239.
20. Abu-Mahfouz MZ, Prasad VM, Santogade P, Cutler AF. Helicobacter pylori recurrence after successful eradication: 5-year follow-up in the United States. Am J Gastroenterol 1997; 92:2025-2028.
21. Goh KL, Navaratnam P, Peh SC. Reinfection and duodenal ulcer relapse in south-east Asian patients following successful Helicobacter pylori eradication: results of a 2-year follow-up. Eur J Gastroenterol Hepatol 1996; 8:1157-1160.
22. Chen TS, Chang FY, Lee SD, Lee SC. Recurrence of H. pylori infection and dyspeptic symptoms after successful eradication in patients cured of duodenal ulcer disease. Hepatogastroenterology 1999; 46:252-256.
23. Oona M, Rago T, Maaroos HI. Long-term recurrence rate after treatment of Helicobacter pylori infection in children and adolescents in Estonia. Scand J Gastroenterol 2004; 39:1186-1191.
24. Ahuja V, Sharma MP. High recurrence rate of Helicobacter pylori infection in developing countries. Gastroenterology 2002; 123:653-654.
25. Coelho LG, Passos MC, Chausson Y, Costa EL, Maia AF, Brandao MJ, et al. Duodenal ulcer and eradication of Helicobacter pylori in a developing country. An 18-month follow-up study. Scand J Gastroenterol 1992; 27:362-366.
26. Soto G, Bautista CT, Roth DE, Gilman RH, Velapatino B, Ogura M, et al. Helicobacter pylori reinfection is common in Peruvian adults after antibiotic eradication therapy. J Infect Dis 2003; 188:1263-1275.
27. Kim JH, Song IS, Park SM, Min YI. Reinfection in Korean patients with peptic ulcer disease following successful eradication of Helicobacter pylori. Korean J Gastroenterol 1998; 31:23-29.
28. Archimandritis A, Balatsos V, Delis V, Manika Z, Skandalis N. 'Reappearance' of Helicobacter pylori after eradication: implications on duodenal ulcer recurrence: a prospective 6 year study. J Clin Gastroenterol 1999; 28:345-347.
29. Fraser AG, Schreuder V, Chua LE, Moore L. Follow up after successful eradication of Helicobacter pylori: symptoms and reinfection. J Gastroenterol Hepatol 1998; 13:555-559.
30. Jeen YT, Lee SW, Kwon SI, Chun HJ, Lee HS, Song CW, et al. Differentiation between reinfection and recrudescence of Helicobacter pylori strains using PCR-based restriction fragment length polymorphism analysis. Yonsei Med J 2001; 42:41-45.
31. Kim N, Kim KY, Kim JY, Jeon HC, Cha SE, Lee KH, et al. A comparative study on the detective methods of Helicobacter pylori. Korean J Internal Med 1994; 47:162-172.
32. Lai JY, De Boer WA, Driessen WM, Geuskens LM. Long-term follow-up after cure of Helicobacter pylori infection with 4 days of quadruple therapy. Aliment Pharmacol Ther 1996; 10:645-650.
33. Lambert JR, Midolo P. The actions of bismuth in the treatment of Helicobacter pylori infection. Aliment Pharmacol Ther 1997; 11 (suppl 1):27-33.
34. Xia HX, Gilvarry J, Beattie S, Hamilton H, Keane CT, Sweeney EC, et al. Recrudescence of Helicobacter pylori infection in patients with healed duodenal ulcer after treatment with different regimens. Am J Gastroenterol 1995; 90:1221-1225.
35. Sheu BS, Yang HB, Su IJ, Shiesh SC, Chi CH, Lin XZ. Bacterial density of Helicobacter pylori predicts the success of triple therapy in bleeding duodenal ulcer. Gastrointest Endosc 1996; 44:683-688.
36. Gunaid AA, Hassan NA, Murray-Lyon IM. Recurrence of Helicobacter pylori infection 1 year after successful treatment: prospective cohort study in the Republic of Yemen. Eur J Gastroenterol Hepatol 2004; 16:1309-1314.
37. Gisbert JP, Arata IG, Boixeda D, Barba M, Canton R, Plaza AG, et al. Role of partner's infection in reinfection after Helicobacter pylori eradication. Eur J Gastroenterol Hepatol 2002; 14:865-871.
38. Leal-Herrera Y, Torres J, Monath TP, Ramos I, Gomez A, Madrazo-de la Garza A, et al. High rates of recurrence and of transient reinfections of Helicobacter pylori in a population with high prevalence of infection. Am J Gastroenterol 2003; 98:2395-2402.
39. Cutler AF, Schubert TT. Long-term Helicobacter pylori recurrence after successful eradication with triple therapy. Am J Gastroenterol 1993; 88:1359-1361.
40. Li C, Ha T, Chi DS, Ferguson DA Jr, Jiang C, Laffan JJ, et al. Differentiation of Helicobacter pylori strains directly from gastric biopsy specimens by PCR-based restriction fragment length polymorphism analysis without culture. J Clin Microbiol 1997; 35:3021-3025.
41. Thoreson AC, Hosseini N, Svennerholm AM, Bolin I. Different Helicobacter pylori strains colonize the antral and duodenal mucosa of duodenal ulcer patients. Helicobacter 2000; 5:69-78.
42. Fraser AG, Bickley J, Owen RJ, Pounder RE. DNA fingerprints of Helicobacter pylori before and after treatment with omeprazole. J Clin Pathol 1992; 45:1062-1065.